FLIP

Molecular switch between apoptosis and necroptosis

Jingjing Gong, Saikartik A. Kumar, Gilian Graham, Addanki P Kumar

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Cancerous growth is one of the most difficult diseases to target as there is no one clear cause, and targeting only one pathway does not generally produce quantifiable improvement. For a truly effective cancer therapy, multiple pathways must be targeted at the same time. One way to do this is to find a gene that is associated with several pathways; this approach expands the possibilities for disease targeting and enables multiple points of attack rather than one fixed point, which does not allow treatment to evolve over time as cancer does. Inducing programmed cell death (PCD) is a promising method to prevent or inhibit the progression of tumor cells. Intricate cross talk among various programmed cell death pathways including cell death by apoptosis, necroptosis or autophagy plays a critical role in the regulation of PCD. In addition, the complex and overlapping patterns of signaling and lack of understanding of such networks between these pathways generate hurdles for developing effective therapeutic approaches. This review article focuses on targeting FLIP (Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein) signaling as a bridge between various PCD processes as an effective approach for cancer management.

Original languageEnglish (US)
Pages (from-to)675-685
Number of pages11
JournalMolecular Carcinogenesis
Volume53
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Cell Death
Apoptosis
Neoplasms
Caspase 1
Autophagy
Therapeutics
Growth
Genes
Proteins

Keywords

  • Apoptosis
  • Autophagy
  • FLIP
  • Necroptosis
  • Programmed cell death

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Medicine(all)

Cite this

FLIP : Molecular switch between apoptosis and necroptosis. / Gong, Jingjing; Kumar, Saikartik A.; Graham, Gilian; Kumar, Addanki P.

In: Molecular Carcinogenesis, Vol. 53, No. 9, 2014, p. 675-685.

Research output: Contribution to journalArticle

Gong, Jingjing ; Kumar, Saikartik A. ; Graham, Gilian ; Kumar, Addanki P. / FLIP : Molecular switch between apoptosis and necroptosis. In: Molecular Carcinogenesis. 2014 ; Vol. 53, No. 9. pp. 675-685.
@article{6d72560519154fed8d4347a3d13c3326,
title = "FLIP: Molecular switch between apoptosis and necroptosis",
abstract = "Cancerous growth is one of the most difficult diseases to target as there is no one clear cause, and targeting only one pathway does not generally produce quantifiable improvement. For a truly effective cancer therapy, multiple pathways must be targeted at the same time. One way to do this is to find a gene that is associated with several pathways; this approach expands the possibilities for disease targeting and enables multiple points of attack rather than one fixed point, which does not allow treatment to evolve over time as cancer does. Inducing programmed cell death (PCD) is a promising method to prevent or inhibit the progression of tumor cells. Intricate cross talk among various programmed cell death pathways including cell death by apoptosis, necroptosis or autophagy plays a critical role in the regulation of PCD. In addition, the complex and overlapping patterns of signaling and lack of understanding of such networks between these pathways generate hurdles for developing effective therapeutic approaches. This review article focuses on targeting FLIP (Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein) signaling as a bridge between various PCD processes as an effective approach for cancer management.",
keywords = "Apoptosis, Autophagy, FLIP, Necroptosis, Programmed cell death",
author = "Jingjing Gong and Kumar, {Saikartik A.} and Gilian Graham and Kumar, {Addanki P}",
year = "2014",
doi = "10.1002/mc.22027",
language = "English (US)",
volume = "53",
pages = "675--685",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - FLIP

T2 - Molecular switch between apoptosis and necroptosis

AU - Gong, Jingjing

AU - Kumar, Saikartik A.

AU - Graham, Gilian

AU - Kumar, Addanki P

PY - 2014

Y1 - 2014

N2 - Cancerous growth is one of the most difficult diseases to target as there is no one clear cause, and targeting only one pathway does not generally produce quantifiable improvement. For a truly effective cancer therapy, multiple pathways must be targeted at the same time. One way to do this is to find a gene that is associated with several pathways; this approach expands the possibilities for disease targeting and enables multiple points of attack rather than one fixed point, which does not allow treatment to evolve over time as cancer does. Inducing programmed cell death (PCD) is a promising method to prevent or inhibit the progression of tumor cells. Intricate cross talk among various programmed cell death pathways including cell death by apoptosis, necroptosis or autophagy plays a critical role in the regulation of PCD. In addition, the complex and overlapping patterns of signaling and lack of understanding of such networks between these pathways generate hurdles for developing effective therapeutic approaches. This review article focuses on targeting FLIP (Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein) signaling as a bridge between various PCD processes as an effective approach for cancer management.

AB - Cancerous growth is one of the most difficult diseases to target as there is no one clear cause, and targeting only one pathway does not generally produce quantifiable improvement. For a truly effective cancer therapy, multiple pathways must be targeted at the same time. One way to do this is to find a gene that is associated with several pathways; this approach expands the possibilities for disease targeting and enables multiple points of attack rather than one fixed point, which does not allow treatment to evolve over time as cancer does. Inducing programmed cell death (PCD) is a promising method to prevent or inhibit the progression of tumor cells. Intricate cross talk among various programmed cell death pathways including cell death by apoptosis, necroptosis or autophagy plays a critical role in the regulation of PCD. In addition, the complex and overlapping patterns of signaling and lack of understanding of such networks between these pathways generate hurdles for developing effective therapeutic approaches. This review article focuses on targeting FLIP (Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein) signaling as a bridge between various PCD processes as an effective approach for cancer management.

KW - Apoptosis

KW - Autophagy

KW - FLIP

KW - Necroptosis

KW - Programmed cell death

UR - http://www.scopus.com/inward/record.url?scp=84906086148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906086148&partnerID=8YFLogxK

U2 - 10.1002/mc.22027

DO - 10.1002/mc.22027

M3 - Article

VL - 53

SP - 675

EP - 685

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 9

ER -